Altered triglycerides and HDL-c are better marker for coronary heart disease in NIDDM
Keywords:NIDDM, Serum triglycerides, HDL-c, Insulin resistance and CHD
Background: Abnormalities that characterizes lipoprotein metabolism in non insulin dependent diabetes mellitus (NIDDM) patients, fasting concentration of triglycerde rich lipoprotein especially very low density lipoprotein (VLDL) are higher, and those of HDL, commonly measured as HDL-c, are lower than among people without diabetes, which leads to increased triglyceride HDL-c ratio and insulin resistance. This type of diabetic dyslipidaemia is major cause of endothelial damage and thus coronary heart disease (CHD).
Methods: The study was carried at the Central Clinical Laboratory MIMSR Medical college Latur , NIDDM patient were selected after attending Medicine OPD MIMSR Medical college Latur, the lipid profile of 50 diabetic patients and 50 healthy subjects were determined and compared.
Results: In the control group I mean values of total cholesterol were 175.55 ± 29.87 mg %, LDL-c 110.60 ± 28.73 mg % , serum triglycerides were 108.39 ± 39.62 mg %,HDL-c were 44.45 ± 6.7 mg% and In the group II serum triglycerides 145.68 ± 68.94 mg% and were significantly increased as compared to group I. The serum HDL-c group II 41.46 ± 6.6 mg % were significantly decreased as compared to group I (P is <0.05).
Conclusions: A characteristic feature of NIDDM is the elevated triglycerides and lowered HDL-c levels, which leads to insulin resistance and CHD.
Ross R. The pathogenesis of atherosclerosis: An update New Eng. J. Med. 1986314:488.
Dewan BD, Malhotra KC, Gupta SP. Epidemiological study of CHD in rural Community in Harayana. Indian Heart Journal. 1974;26:66-78.
Sarvothan SG, Berry JD. Prevalance of CHD in an Urban population in Northan India. Circulation. 1968;25:939-53.
Enas Ea, Garg A, Davidson MA. Coronary artery disease and It’s risk factors in 1st generation immigrant Asian Indian to the United State of America. Indian heart J. 1996;48:343-53.
Castelli WP, Andreson KA. Population at risk prevalence high cholesterol level in hypertensive patients. Framingham study. Am. J. Med. 1986;80,(2A):23-28.
Bhoraskar AS, Raheja DS. Diabetes and cardiovascular disease Do Asian Indians have a high ethenic susceptibility. J.A.P.I. 1997;34:72-8.
World health organization (WHO). Prevention of Diabetes Mellitus in WHO Technical Report Series No 844. Geneva; WHO. 1994.
Panzram G. Mortality Survival in type 2 (non- insulin dependent) Diabetes mellitus. Diabetologia. 1987;30:123-31.
Meigs JB, Singer DE Sullivan LM. Metabolic control &Prevalent cardiovascular disease in non-insulin dependent diabetes mellitus (NIDDM); The NIDDM patient outcomes research group. Am J. Med. 1997;102;38-47.
Taskinen MR. Hyperlipidemia in diabetes. Bailliere Clin. Endocrinol Metab. 1990;4;743-75.
Howard BV. Lipoprotein metabolisim in diabetes mellitus. J. Lipid Res. 1987;28;613-28.
Zimmet PZ. Hyperinsulinaemia how innocent a bystander. Diabetes care. 1993;16:56-70.
Mc Laughlin T, Abbasi F, Cheal K, Cheal K, Chu J, Lamendola C, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802-9.
Gaziano JM, Hennekens CH, O’Donnell CJ. Fasting triglycerides, high density lipoprotein,and risk of myocardial infarction.Circulation. 1997;96:2520-5.
Levy FRI, Fridickson DS. Friedwald formula, In John D Bauer clinical laboratory methods. 9th ed. 1972:555.
Kahari SM, Virtanen KS, Tasiknen MR. HDLs containing apolipoprotiens A-I and A-II (LpA-I; A-II) as markers of coronary artery disease in men with NIDDM. Circulation. 1995;92:364-70.
Taskinen MR, Lipoprotein lipase in diabetes. Diabetes Metab Rev. 1987;3;551-70.
Taskinen MR, Lahdenpera S, Syvanne M. New insights into lipid metabolism in non-insulin-diabetes mellitus. Ann Med. 1996;28;335-40.
Edward, P, Feener, George, L. King. Vascular dysfunction in diabetes mellitus. Lancet. 199;350:09-13.
Velloso LA, Folli F, Sun XJ, White MF. Cross talk between the Insulin and angiotensin signaling systems. Proc. Nat. Acad. Sci. U.S.A. 1996;93:12490-5.
Miesenbock G, Patsch JR. Postparandial-hyperlipidemia. The search for the Atherogenic lipoprotein. Curr Opin Lipidol. 1992;3:196-201.
Grundy SM, Vega Gl. Two different views of the relationship of hypertriglyceridemia to coronary heart disease; implication for treatment. Arch Intern Med. 1992;152:28-34.